Home
About Us
Issues
Authors
Reviewers
Users
Subscription
Our Other Journals
Neonatal Database
Neonatal Database Download
Neonatal Journal Abstracts
Feedback
Salient Features
Open Access
Editorial Board
Publisher
Publication Ethics & Malpractice
Journal Policy
Peer Review Process
Contact Us
Current Issue
Forthcoming
Article Archive
Access Statistics
Simple Search
Advanced Search
IJNMR Performance
Submit an Article
Instructions
Assistance
Publication Fee
Paid Services
Apply As Reviewer
Acknowledgment
Register Here
Register For Article Submission
Login Here
Login For Article Submission
Annual
Buy One Issue
Payment Options
How to Order
JCDR
IJARS
NJLM

 

Welcome : Guest

Users Online :

 

 

 

 

 

 

 

 

Case report

Year :2022 Month : July Volume : 10 Issue : 3 Page : PC01 - PC03 Full Version

Achromobacter xylosoxidans Causing Late-onset Sepsis with Pneumonia in a Term Neonate


Basany Laxman, Aepala Roja
1. Neonatologist, Department of Neonatology, Dolphin Kids Hospital, Hanamkonda, Telangana, India. 2. Neonatologist, Department of Neonatology, Dolphin Kids Hospital, Hanamkonda, Telangana, India.
 
Correspondence Address :
Basany Laxman,
Flat 301, B Block, Legend Galaxy, Kothapet, Hyderabad, Telangana, India.
E-mail: laxmanbasani@yahoo.co.in
 
ABSTRACT

: Achromobacter xylosoxidans (A. xylosoxidans), is an aerobic gram negative motile bacillus that rarely causes infection in healthy adults and is exceptionally rare in neonates. A. xylosoxidans is ubiquitous in nature, causing nosocomial infections especially in debilitated and immunocompromised patients. Few outbreaks caused by this organism were reported in Neonatal Intensive Care Units (NICU) along with sporadic cases in neonates. A 3-week-old term neonate presented with late-onset sepsis and pneumonia caused by A. xylosoxidans that was successfully treated with antibiotics and supportive care. Awareness regarding this uncommon pathogen and initiation of appropriate antibiotic therapy would improve the outcome and prevent mortality.
Keywords : Antibiotics, Bacillus, Nosocomial infection
DOI and Others : DOI: 10.7860/IJNMR/2022/58884.2355

Date of Submission: Jul 04, 2022
Date of Peer Review: Sep 13, 2022
Date of Acceptance: Sep 16, 2022
Date of Publishing: Sep 30, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jul 06, 2022
• Manual Googling: Sep 15, 2022
• iThenticate Software: Sep 20, 2022 (20%)

Etymology: Author Origin
 
Case Report

A 3-week-old term male neonate weighing 3050 grams was born to a 25-year-old primigravida mother by emergency caesarean section (Indication: foetal distress) at 39 weeks of gestation. The mother had noticed decreased foetal movements but there is no history of maternal fever, urinary tract infection or rupture of membranes. Liquor was clear. APGAR scores were 8 and 9 at 1 and 5 minutes of age respectively. Baby was exclusively on breastfeeds. He developed cough and hurried breathing on 21st day of life and was admitted in a private hospital. He was treated with antibiotic (cefotaxim) and supplemental oxygen through nasal cannula for 4 days. The child was then referred for further care in view of persistent respiratory distress.

On examination, the neonate weighed 3360 grams and was febrile with temperature of 101°F. His respiratory rate was 72/min, with subcostal retractions and DOWNE score was 4/10. Sepsis screen was positive [C-Reactive Protein (CRP)]: 23.8 mg/L]. He required Fraction of Inspired Oxygen (FiO2) of 0.50 to maintain Oxygen saturation (SpO2) of 96%. Chest X-ray showed bilateral patchy opacities and air bronchograms suggestive of pneumonia. Blood culture was sent and antibiotics (Piperacillin-Tazobactam and Amikacin) were commenced in view of pneumonia. The baby continued to have intermittent fever for next 5 days. Blood culture done on BACTEC 9050 (BD Diagnostic Systems, USA) was positive at 24 hours. Gram stain showed presence of gram negative bacilli. Subculture on MacConkey’s agar showed catalase and oxidase positive, motile, gram negative rods isolated in pure culture in a concentration of >106/mL that oxidised xylose and glucose. Automated bacterial identification and antimicrobial susceptibility testing were done using MicroScan autoSCAN-4 (Siemens, Germany). The isolate was identified as A. xylosoxidans, which was sensitive to piperacillin-tazobactam, fluoroquinolones, cefoperazone, carbapenems, colistin and resistant to gentamicin, amikacin, ampicillin, amoxicillin, cefotaxime and ceftriaxone.

Antibiotics were changed to meropenem and levofloxacin as per culture sensitivity report. He responded well to higher antibiotics, became afebrile, accepted feeds well and was weaned to room air. Head ultrasound, urine examination and Cerebrospinal Fluid (CSF) examination were normal. The infant did not have any seizures or encephalopathy. He required supplemental oxygen for 1 week. Repeat septic screen was negative (CRP: 5.8 mg/L). Baby received 10 days of higher antibiotics and was discharged after 14 days of NICU stay. The neonate had normal growth and development at 6 months of age.
 
 
Discussion

A. xylosoxidans, an aerobic gram negative motile bacillus is first isolated in 1971 from purulent ear discharges and named by Yabuuchi E and Oyama A for seven strains of gram negative, non fermentative bacteria with peritrichous flagella that produce acid from xylose (1). They had described the unique characteristics of 55 strains of A. xylosoxidans isolated from a wide range of clinical material. It’s role as a pathogen is underestimated as it is often confused with Pseudomonas species, but unlike pseudomonas, Achromobacter has peritrichous flagella (1),(2). A. xylosoxidans is ubiquitous in the environment, causing infections in debilitated and immunocompromised patients with only few cases being reported in neonates (1),(2),(3). Though A. xylosoxidans has been isolated from the urine, blood, respiratory tract, spinal fluid, indwelling catheters and ears, it is often isolated along with other microorganisms, making it difficult to assess the clinical significance of its isolation. A. xylosoxidans was found in environmental habitats such as surface water, contaminated chlorhexidine solution, incubators, humidifiers, faucets, sinks and dialysate fluid (2).

Literature search of PubMed, EMBASE, MEDLINE and Google scholar was done from 1970 till June 2022 using the MeSH words: infection, neonate, sepsis and A. xylosoxidans, it showed around 105 reported cases of A. xylosoxidans associated infections in neonates (Table/Fig 1). Achromobacter is a rare but significant pathogen causing nosocomial and opportunistic infections in neonates (3).

Foley JF et al., reported 6 cases of infections due to A. xylosoxidans in neonates with fatal outcome (3). Hearn YR and Gander RM from USA had reported early onset sepsis due to in-utero transmission with fatal outcome (4). Kumar A et al., from India reported an outbreak of infections due to this organism in 8 neonates, but could not identify the source of infection (5). Molina-Cabrillana J et al., from Spain reported an outbreak of infection in NICU due to contaminated chlorhexidine solution affecting 52 neonates (6). A. xylosoxidans infection was reported from India in a 3-day-old neonate with early onset sepsis, keratoconjunctivitis and meningitis (7).

A. xylosoxidans, is reported to cause sepsis, meningitis, osteomyelitis, pneumonia, keratoconjunctivitis, endocarditis, and ventriculitis. The bacteremia is often associated with indwelling catheters, implanted devices, contaminated parenteral solutions, ventriculostomy drains, contaminated water, antiseptic solutions and vascular catheters (8),(9). A. xylosoxidans infection is usually associated with prematurity, total parenteral nutrition, use of broad-spectrum antibiotics, surgical procedures, irrigation of surgical wounds, implanted devices and central venous catheters, but none of these risk factors were present in our case.

Though still uncommon in NICU, infection with A. xylosoxidans is worrisome because of intrinsic resistance to commonly used antibiotics including ampicillin, aminoglycosides, ciprofloxacin and first generation cephalosporins. It is usually susceptible to ticarcillin, trimethoprim-sulfamethoxazole, piperacillin and imipenem (10). A. xylosoxidans infections in neonatal period is associated with high mortality (3),(4),(8),(9),(10),(11),(12),(13),(14). Management includes prompt initiation of antibiotic therapy to which this organism is susceptible along with supportive care. A tertiary hospital from India reported a mortality of 26.7% in a nosocomial outbreak due to A. xylosoxidans (5).

In this case, baby presented at 3 weeks of life with respiratory distress and infection was presumed to be acquired either from community or in the referral hospital from humidified oxygen. Blood culture and environmental sampling were not done in referral hospital and the source of infection was not identified. After isolation of the index case, periodic surveillance of environmental samples and hands of healthcare personnel was done and there was no episode of any nosocomial infection due to this organism over the next 12 months.
 
 
Conclusion

This case report highlights that A. xylosoxidans is an uncommon pathogen in India and there is a need for epidemiological surveillance in hospitals to identify the source of this organism which can cause nosocomial outbreaks with high mortality because of innate resistance to ampicillin, aminoglycosides and first generation cephalosporins. This organism is often confused with Pseudomonas and is underreported. Achromobacter causes two important reactions, an alkaline reaction in Oxidation-Fermentation (O-F) medium and oxidation of xylose which help in its identification. Use of aseptic precautions by healthcare personnel and proper sterilisation of equipment prevents nosocomial outbreaks. Awareness regarding this uncommon pathogen and initiation of appropriate antibiotic therapy improves the outcome and prevents mortality.
 
vioft2nnt8|20168B9C207A|jcdrorgin_ijnmr_frontend|Articles|article_references|0xe3ff9b9a0c0000002402000001002000
REFERENCES
1.
Yabuuchi E, Oyama A. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol Res. 1971;15(5):477-81.   [Google Scholar]  [CrossRef]  [PubMed]
2.
Holmes B, Snell JJ, Lapage SP. Strains of Achromobacter xylosoxidans from clinical material. J Clin Pathol Res. 1977;30(7):595-601.   [Google Scholar]  [CrossRef]  [PubMed]
3.
Foley JF, Gravelle CR, Englehard WE, Chin TD. Achromobacter septicemia-fatalities in prematures. I. Clinical and epidemiological study. Am J Dis Child Res. 1961;101:279-88.   [Google Scholar]  [CrossRef]
4.
Hearn YR, Gander RM. Achromobacter xylosoxidans. An unusual neonatal pathogen. Am J Clin Pathol Res.1991;96(2):211-14.   [Google Scholar]  [CrossRef]  [PubMed]
5.
Kumar A, Ray P, Kanwar M, Sethi S, Narang A. Investigation of hospital-acquired infections due to Achromobacter xylosoxidans in a tertiary care hospital in India. J Hosp Infect Res. 2006;62(2):248-50.   [Google Scholar]  [CrossRef]  [PubMed]
6.
Molina-Cabrillana J, Santana-Reyes C, González-García A, Bordes-Benítez A, Horcajada I. Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution. Eur J Clin Microbiol Infect Dis Res 2007;26(6):435-37.   [Google Scholar]  [CrossRef]  [PubMed]
7.
Ramaswamy VV, Rao GV, Suryanarayana N. A Rare cause of ophthalmia neonatorum-achromobacter denitrificans. Journal of Clinical and Diagnostic Research Res. 2018;12(10):SD01-SD02.   [Google Scholar]  [CrossRef]
8.
Boukadida J, Monastiri K, Snoussi N, Jeddi M, Berche P. Nosocomial neonatal meningitis by Alcaligenes xylosoxidans transmitted by aqueous eosin. Pediatr Infect Dis J Res. 1993;12(8):696-97.   [Google Scholar]  [CrossRef]  [PubMed]
9.
Turel O, Kavuncuoglu S, Hosaf E, Ozbek S, Aldemir E, Uygur T, et al. Bacteremia due to Achromobacter xylosoxidans in neonates. Clinical features and outcome. Braz J Infect Dis Res. 2013;17(4):450-54.   [Google Scholar]  [CrossRef]  [PubMed]
10.
Puthucheary SD, Ngeow YF. Infections with Achromobacter xylosoxidans. Singapore Med J Res. 1986;27(1):58-62.   [Google Scholar]
11.
Sindhu SS. Achromobacter meningitis in the newborn. J Singapore Paediatr Soc Res. 1971;13(1):31-36.   [Google Scholar]
12.
Lee SL, Tan KL. Achromobacter meningitis in the newborn. Singapore Med J Res. 1972;13(5):261-65.   [Google Scholar]
13.
Shie SS, Huang CT, Leu HS. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan. J Microbiol Immunol Infect Res. 2005;38(4):277-82.   [Google Scholar]
14.
Namnyak SS, Holmes B, Fathalla SE. Neonatal meningitis caused by Achromobacter xylosoxidans. J Clin Microbiol Res. 1985;22(3):470-71.   [Google Scholar]  [CrossRef]  [PubMed]
15.
Manjra AI, Moosa A, Bhamjee A. Fatal neonatal meningitis and ventriculitis caused by multiresistant Achromobacter xylosoxidans. A case report. S Afr Med J Res. 1989;76(10):571-73.  [Google Scholar]
 
 
 
 

In This Article

  • Abstract
  • Material and Methods
  • Results
  • Discussion
  • Conclusion
  • References

Article Utilities

  • Readers Comments
  • Article in PDF
  • Citation Manager
  • How to Cite
  • Article Statistics
  • Link to PUBMED
  • Print this Article
  • Send to a Friend

Quick Links

REVIEWER
ACCESS STATISTICS
Home  |  About Us  |  Online First  |  Current Issue  |  Simple Search  |  Advance Search  |  Register  |  Login  |  Contact  | 
IJNMR Pre-Publishing  |  Reviewer  |  Articles Archive  |  Access Statistics
© 2023 INDIAN JOURNAL OF NEONATAL MEDICINE & RESEARCH (IJNMR), ISSN : 2277-8527.
EDITORIAL OFFICE : 3rd Floor, Hemraj Jain Building, 4352 Pahari Dhiraj, Delhi, India 110006,Phone : 01123848553

* This Journal is owned and run by medical professionals *